Publication | Closed Access

Factor Eight Inhibitor Bypassing Agent (FEIBA) for Reversal of Target-Specific Oral Anticoagulants in Life-Threatening Intracranial Bleeding

ThrombosisTarget-specific Oral AnticoagulantsMedicineHematologyPharmacologyVascular SurgeryLife-threatening Intracranial BleedingHemostasisPlatelet AntagonistBrain InjuryNeurologyPharmacotherapyBleeding DisorderCerebral Blood FlowCoagulopathyStrokeAnticoagulantHealth Sciences